Cathy Mendelsohn

14PUBLICATIONS
54CO-AUTHORS
BiomaterialsCancer geneticsPredictive and prognostic markersSurface water quality processes and contaminated sediment assessmentMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 22, 2026
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models.

|Sep 25, 2025
Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer.

Sangkyou Lee, Sung Yun Jung, Pawel Kuś

|Sep 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies.

Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess

|Nov 18, 2024
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy.

Mathieu Rouanne, Noah Chen, Dylan L Mariuzza

|Sep 27, 2024
Nur77 protects the bladder urothelium from intracellular bacterial infection.

Christina A Collins, Chevaughn Waller, Ekaterina Batourina

|Aug 02, 2024
Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer.

Sakina A Plumber, Tiffany Tate, Hikmat Al-Ahmadie

Pageof 3

Frequent Collaborators

3 joint publications

Chao Lu

2 joint publications

Miguel Verbitsky

2 joint publications

David A Fasel

2 joint publications

Matthew G Sampson